61775-19-7 - Names and Identifiers
61775-19-7 - Physico-chemical Properties
Molecular Formula | C16H14O5
|
Molar Mass | 286.28 |
Density | 1.370±0.06 g/cm3(Predicted) |
Melting Point | 231-232 °C |
Boling Point | 555.9±50.0 °C(Predicted) |
Specific Rotation(α) | ?14 (c, 0.17 in CHCl3) |
pKa | 7.35±0.40(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
61775-19-7 - Risk and Safety
Hazard Symbols | N - Dangerous for the environment
|
Risk Codes | 50 - Very Toxic to aquatic organisms
|
Safety Description | 61 - Avoid release to the environment. Refer to special instructions / safety data sheets.
|
UN IDs | UN 3077 9 / PGIII |
WGK Germany | 3 |
61775-19-7 - Introduction
5-O-Methylnaringenin is a natural compound that belongs to the class of flavonoids. It can be isolated from some plants, such as May tea and honey wax chrysanthemum.
Properties, 5-O-Methylnaringenin is a white crystalline solid with a bitter taste. It is stable at normal temperature and soluble in organic solvents such as ethanol and dimethyl sulfoxide.
This compound is widely used in medicine and nutrition. Studies have shown that 5-O-Methylnaringenin has a variety of beneficial biological activities, including antioxidant, anti-inflammatory, anti-tumor and antibacterial effects. It can be used to treat diseases such as hypertension, diabetes and cancer, and can also be used as a natural anti-aging agent.
In terms of preparation method, 5-O-Methylnaringenin can be prepared by separation and purification from plant extracts. A common method is extraction using a solvent such as ethyl acetate, followed by purification by techniques such as crystallization and column chromatography to obtain the compound.
Regarding safety information, no significant toxicity of 5-O-Methylnaringenin has been reported. However, such as other compounds, it is still necessary to pay attention to safe operation and avoid contact with eyes, skin and respiratory tract. In addition, in order to ensure safety, it is recommended that when applying this compound in the medical and nutritional fields, necessary toxicity assessment and reasonable dosage control should be carried out first.
Last Update:2024-04-10 22:30:50